MetaCap

Strata Critical Medical Inc. Class A (SRTA)

NASDAQ: SRTAHealth CareMedical/Nursing ServicesUSD

4.56-0.27 (-5.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SRTA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$407.30M
EPS (TTM)
-$0.24
52-week range
3.95 – 6.50
Day range
4.54 – 4.85
Volume / Avg
1.13M / 982.75K
Beta
—

52-week range

$3.95$6.50

SRTA stock today

Strata Critical Medical (SRTA) closed at $4.56 on Nov 20, down 5.59% (-$0.27), versus the S&P 500's 3.70% decline. At this level, SRTA sits in the middle of its 52-week range of $3.95 to $6.50: 29.8% below the high, set on May 28, 2026 and 15.4% above the low. SRTA is down 5.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 8.6%.

Strata Critical Medical has posted a net loss over the last twelve months (EPS of -$0.24), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Strata Critical Medical

Company profile

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical.

Industry
Medical/Nursing Services
CEO
Ms. Melissa M. Tomkiel J.D.
Headquarters
New York, NY
Employees
327
IPO year
2019

Financial highlights

Full financials

In fiscal 2025, Strata Critical Medical generated $197.1 million in revenue, up 34.3% from fiscal 2024. Net income was $41.3 million, for a net margin of 21.0% versus a median of -21.8% in the prior 5 years. Gross margin was 20.9% (up from 20.2%) and operating margin -11.3%.

Strata Critical Medical annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$197.14M$146.82M$225.18M$146.12M$50.53M
Growth+34.28%-34.80%+54.11%+189.20%—
Net income$41.35M$-27.31M$-56.08M$-27.26M$-40.05M
EPS (diluted)$0.50$-0.35$-0.76$-0.38$-0.93

Analyst forecast

Forecast

Consensus (4 analysts)

strong_buy

Avg. price target

$9.63+111.18%

  • Strong buy 0
  • Buy 4
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $8.00High $13.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$-0.09 vs $0.01
Surprise
-1000.00%

SRTA news

All SRTA news

Strata Critical Medical peers

Health Care sector
SRTA peer companies
CompanyPrice% ChgMarket capCompare
PIIIP3 Health Partners Inc. Class A1.69-9.14%$350.24Mvs SRTA
STLNStarling Oncology Inc.3.00-5.66%$305.97Mvs SRTA
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs SRTA
AUNAAuna SA Class A3.66-6.15%$271.05Mvs SRTA
OMDAOmada Health Inc.11.87-5.04%$736.39Mvs SRTA
LFMDLifeMD Inc.1.45-9.40%$69.84Mvs SRTA
NAKANakamoto Inc.3.44-15.89%$63.11Mvs SRTA
EUDAEUDA Health Holdings Limited Class A15.96-7.69%$47.79Mvs SRTA

Indexes, lists and sector

Strata Critical Medical stock FAQ

What is Strata Critical Medical's stock price today?

SRTA last traded at $4.56 as of Nov 20, 4:00 PM EST, down 5.59% on the day. Prices are delayed at least 15 minutes.

Who is Strata Critical Medical's CEO?

Ms. Melissa M. Tomkiel J.D. is the chief executive officer of Strata Critical Medical Inc. Class A, which has about 327 employees.

What is the SRTA 52-week high?

The 52-week high for SRTA is $6.50 and the 52-week low is $3.95. The stock is currently 29.8% below its high.

Compare SRTA